Product Images Quinapril And Hydrochlorothiazide 20/25

This text is a list of medical conditions or symptoms. It includes terms related to respiratory, digestive, and neurological systems, such as chest pain, vertigo, dyspepsia, and respiratory distress. It seems to refer to a chart or record-keeping system for patients who are monitored or treated for these conditions.*

This appears to be a medical report and lists various symptoms and conditions related to different body systems. It also mentions a warning about angioedema being reported in patients receiving quinapl.*

This is a prescription drug with the NDC code 69097-829-05. The drug contains Quinapril HCI 20 mg and Hydrochlorothiazide 12.5 mg in each tablet, and is manufactured by Cipla for Cipla USA, Inc. The tablets need to be stored at a controlled-room temperature. The dosage and usage details can be found in the prescribing information. The text also has some manufacturing details.*

This is a description of a medication called Quinapril and Hydrochlorothiazide. It is produced by Cipla and each tablet contains 20mg of quinapril HC1, USP and 25mg of hydrochlorothiazide, USP. It is a prescription-only medication and comes in a container with 90 tablets. Dosage and usage instructions can be found alongside prescribing information. It should be stored at a controlled room temperature between 20°C and 25°C. The medication is manufactured by InvaGen Pharmaceuticals, a subsidiary of Cipla.*